Intended for healthcare professionals

Letters Covid-19: What next for Valneva vaccine?

Valneva could appeal to the vaccine hesitant and may be more effective for longer

BMJ 2022; 376 doi: (Published 11 January 2022) Cite this as: BMJ 2022;376:o48
  1. Shyan Goh, orthopaedic surgeon
  1. Sydney, Australia
  1. sgoh{at}

The UK government’s treatment of the Valneva covid-19 vaccine is appalling.1

In September 2021, the health secretary, Sajid Javid, was quoted as saying of Valneva to the House of Commons: “It was also clear to us that the vaccine in question that the company was developing would not get approval by the Medicines and Healthcare Products Regulatory Agency (MHRA) here in the UK.”2

Later, in Hansard, this was amended to “the vaccine in …

View Full Text

Log in

Log in through your institution


* For online subscription